Read + Share
Amedeo Smart
Independent Medical Education
Li X, Liu J, Guo M, Cai H, et al. NSCLC patients with MET non-exon-14 mutations rather than MET exon 14 mutations response to immune checkpoint inhibitors. Lung Cancer 2021;152:202-204.PMID: 33422364
Email
LinkedIn
Facebook
Twitter
Privacy Policy